Volcano Corporation designs, develops, manufactures and commercializes a suite of precision guided therapy tools including intravascular ultrasound (IVUS) and fractional flow reserve (FFR) products. The Company markets its products to physicians, nurses and technicians who perform endovascular based coronary and peripheral interventional procedures in hospitals and to other personnel who make purchasing decisions on behalf of hospitals. The Company's products consist of consoles that are marketed as stand-alone units or as units that can be integrated into a variety of hospital-based interventional surgical suites called catheterization laboratories, or cath labs. The Company has developed customized cath lab versions of these consoles. The Company sells products directly to customers in the United States, Japan, certain European markets and South Africa. The Company's products include consoles, IVUS products, FFR products, Pioneer plus re-entry catheter and crux VCF system.
Industry, Sector and Symbol
Industry N/A
Sub-IndustryHealth Care Equipment
SectorN/A
SymbolNASDAQ:VOLC
CUSIP92864510
Phone+1-800-2284728
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins-8.21%
Return on Equity-10.48%
Return on Assets-3.68%
Miscellaneous
EmployeesN/A
Outstanding SharesN/A
Volcano (NASDAQ:VOLC) Frequently Asked Questions
What is Volcano's stock symbol?
Volcano trades on the NASDAQ under the ticker symbol "VOLC."
How were Volcano's earnings last quarter?
Volcano Corp (NASDAQ:VOLC) released its quarterly earnings data on Thursday, November, 6th. The healthcare company reported ($0.04) earnings per share for the quarter, topping the consensus estimate of ($0.06) by $0.02. The healthcare company had revenue of $97.50 million for the quarter, compared to analyst estimates of $96 million. Volcano had a negative net margin of 8.21% and a negative return on equity of 10.48%. Volcano's revenue for the quarter was up 1.8% compared to the same quarter last year. During the same period in the previous year, the business earned ($0.08) EPS. View Volcano's Earnings History.
Has Volcano been receiving favorable news coverage?
News stories about VOLC stock have trended somewhat positive this week, Accern Sentiment reports. Accern identifies negative and positive press coverage by reviewing more than twenty million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Volcano earned a news impact score of 0.07 on Accern's scale. They also assigned media headlines about the healthcare company an impact score of 46.00 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company's share price in the near term.
How do I buy shares of Volcano?
Shares of VOLC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How big of a company is Volcano?
Volcano has a market capitalization of $928.46 million.
How can I contact Volcano?
Volcano's mailing address is 3721 Valley Centre Dr Ste 500, SAN DIEGO, CA 92130-3328, United States. The healthcare company can be reached via phone at +1-800-2284728.
MarketBeat Community Rating for Volcano (VOLC)
MarketBeat's community ratings are surveys of what our community members think about Volcano and other stocks. Vote "Outperform" if you believe VOLC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe VOLC will underperform the S&P 500 over the long term. You may vote once every thirty days.
